Vivo Capital is a global healthcare investment specialist with a multi-strategy platform spanning venture capital, private equity and public equity investments. The firm focuses on expanding healthcare access and catalyzing innovation through its Ecosystem Strategy, supporting companies across the global healthcare landscape. Headquartered to serve a worldwide market, Vivo Capital emphasizes strong track records in IPOs, M&A, and regulatory approvals to drive growth in bioscience and pharmaceutical sectors.